General Information of the Compound
| Compound ID |
CP0511900
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(3S,10R,13S)-10,13-Dimethyl-17-tetrazol-2-yl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C20H28N4O
|
||||||||||||||||||
| Molecular Weight |
340.471
|
||||||||||||||||||
| Canonical SMILES |
C[C@]12CCC3C(CC=C4C[C@@H](O)CC[C@]34C)C1CC=C2n1ncnn1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C20H28N4O/c1-19-9-7-14(25)11-13(19)3-4-15-16-5-6-18(24-22-12-21-23-24)20(16,2)10-8-17(15)19/h3,6,12,14-17,25H,4-5,7-11H2,1-2H3/t14-,15?,16?,17?,19-,20-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
MHNCROJKVCNBCY-MXRZLSGWSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound